Zota Health Care LImited (ZOTA) — Financial Results

· NSE 🔴 High Importance Neutral
📢 Key Event
FY26 revenue grew 84% YoY to ₹53,865.75 lakhs with EBITDA turning positive at ₹2,597.73 lakhs
🔄 What Changed
Revenue grew 84% YoY to ₹53,865.75 lakhs; EBITDA turned positive at ₹2,597.73 lakhs; store network expanded to 2,579 locations; 21.80% stake acquired in EHBCPL
🔮 What's Next
Targeting 5,000+ Davaindia stores by FY29; will moderate expansion pace in next two quarters to focus on profitability and operating efficiencies
💡 Investor Takeaway
The company is scaling its retail pharmacy network profitably while strengthening its export and OTC business through strategic acquisitions.

Zota Health Care Limited reported consolidated revenue of ₹53,865.75 lakhs for FY26, driven by 84% YoY growth in Davaindia revenue to ₹41,741 lakhs, with EBITDA turning positive at ₹2,597.73 lakhs. The company expanded its store network to 2,579 active locations (1,656 COCO and 923 FOFO) as of March 31, 2026, and acquired a 21.80% stake in EHBCPL, increasing its total ownership to 87.78%. Management highlighted plans to moderate expansion pace in FY27 while targeting 5,000+ stores by FY29.

📄 View Original Announcement (PDF)

About Zota Health Care LImited (ZOTA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹4,182.92 Cr P/E: -82.4

View full ZOTA stock details →

📡 Get AI alerts when ZOTA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ZOTA — Free

📊 More ZOTA filings

See all ZOTA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ZOTA files new disclosures

Track ZOTA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ZOTA — Free

Free account · 2 AI queries/day